Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)

SHA:603077 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,821	6,999	3,064	4,591	1,711	845.86
Trading Asset Securities	-	-	-	-	56.89	-
Cash & Short-Term Investments	6,821	6,999	3,064	4,591	1,768	845.86
Cash Growth	165.76%	128.43%	-33.26%	159.70%	109.01%	6.19%
Accounts Receivable	1,755	2,043	2,049	2,568	1,656	1,682
Other Receivables	52.23	30.07	34.35	23.09	19.55	14.75
Receivables	1,807	2,073	2,084	2,591	1,675	1,697
Inventory	4,060	4,545	4,403	2,076	912.2	633.27
Other Current Assets	385.56	385.99	303.87	460.25	287.84	141.95
Total Current Assets	13,074	14,003	9,855	9,719	4,643	3,318
Property, Plant & Equipment	9,904	9,952	9,684	9,483	8,295	7,513
Long-Term Investments	877.47	857.45	667.27	677.37	661.99	645.59
Goodwill	1,838	1,838	1,838	1,838	1,904	1,904
Other Intangible Assets	2,667	2,389	2,200	2,143	1,967	1,018
Long-Term Deferred Tax Assets	135.42	127.23	50.38	110.3	25.83	85.94
Long-Term Deferred Charges	220.82	174.48	105.46	34.01	7.29	9.85
Other Long-Term Assets	575.96	308.09	142.16	97.84	417.19	245.29
Total Assets	29,294	29,650	24,542	24,103	17,922	14,740
Accounts Payable	983.53	2,108	1,877	1,877	1,156	1,042
Accrued Expenses	45.39	76.21	103.01	91.37	126.24	79.69
Short-Term Debt	2,552	2,353	1,168	1,222	1,171	1,602
Current Portion of Long-Term Debt	434.59	745.33	342.32	164	95	279
Current Portion of Leases	-	5.97	2.44	2.44	-	-
Current Income Taxes Payable	61.78	14.87	55.01	95.71	140.79	21.78
Current Unearned Revenue	149.42	45.1	96.6	235.07	371.54	113.74
Other Current Liabilities	38.04	26.15	25.43	46.5	62.07	13.87
Total Current Liabilities	4,265	5,375	3,670	3,734	3,123	3,152
Long-Term Debt	5,932	4,936	431.17	408.48	68.09	262.4
Long-Term Leases	13.89	14.52	24.94	21.54	37.06	-
Long-Term Unearned Revenue	127.36	130.17	75.25	79.03	16.79	15.86
Long-Term Deferred Tax Liabilities	190.15	187.92	122.75	96.02	39.99	2.3
Total Liabilities	10,528	10,643	4,324	4,339	3,285	3,433
Common Stock	8,831	8,831	8,831	8,831	8,831	8,831
Additional Paid-In Capital	948.65	1,035	1,125	1,095	470.46	212.9
Retained Earnings	10,176	10,078	10,204	9,313	5,642	2,619
Treasury Stock	-1,790	-1,697	-650.37	-150	-700	-520.07
Comprehensive Income & Other	356.44	379.15	66.4	29.45	1.9	-1.24
Total Common Equity	18,523	18,626	19,575	19,118	14,245	11,142
Minority Interest	242.82	380.13	643.04	644.86	391.84	165.66
Shareholders' Equity	18,766	19,007	20,218	19,763	14,637	11,307
Total Liabilities & Equity	29,294	29,650	24,542	24,103	17,922	14,740
Total Debt	8,933	8,055	1,969	1,818	1,372	2,144
Net Cash (Debt)	-2,111	-1,056	1,096	2,773	396.4	-1,298
Net Cash Growth	-	-	-60.49%	599.57%	-	-
Net Cash Per Share	-0.26	-0.12	0.13	0.32	0.05	-0.15
Filing Date Shares Outstanding	7,974	8,022	8,512	8,725	8,394	8,518
Total Common Shares Outstanding	7,974	8,022	8,512	8,725	8,394	8,518
Working Capital	8,810	8,629	6,185	5,985	1,520	165.62
Book Value Per Share	2.32	2.32	2.30	2.19	1.70	1.31
Tangible Book Value	14,017	14,399	15,537	15,137	10,374	8,219
Tangible Book Value Per Share	1.76	1.79	1.83	1.73	1.24	0.96
Buildings	-	3,766	3,564	2,856	-	2,065
Machinery	-	11,303	11,677	10,357	-	7,313
Construction In Progress	-	2,354	1,174	1,885	-	2,320

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.